BCL11B and neoplasm: The screens across many cancer types described here provide evidence for widespread haplo- and quasi-insufficiency in tumor evolution, and we show in mouse models that even small or temporal gene expression changes of tumor suppressors, such as Bcl11b, can be oncogenic.